304 related articles for article (PubMed ID: 11166970)
21. Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats.
Ko MC; Tuchman JE; Johnson MD; Wiesenauer K; Woods JH
Psychopharmacology (Berl); 2000 Feb; 148(2):180-5. PubMed ID: 10663433
[TBL] [Abstract][Full Text] [Related]
22. Antihyperalgesic, Antiallodynic, and Antinociceptive Effects of Cebranopadol, a Novel Potent Nociceptin/Orphanin FQ and Opioid Receptor Agonist, after Peripheral and Central Administration in Rodent Models of Neuropathic Pain.
Tzschentke TM; Linz K; Frosch S; Christoph T
Pain Pract; 2017 Nov; 17(8):1032-1041. PubMed ID: 28112482
[TBL] [Abstract][Full Text] [Related]
23. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
24. The antinociceptive effect of the mu-opioid fentanyl is reduced in the presence of the alpha(2)-adrenergic antagonist idazoxan in inflammation.
Herrero JF; Solano RE
Brain Res; 1999 Sep; 840(1-2):106-14. PubMed ID: 10517958
[TBL] [Abstract][Full Text] [Related]
25. Ultralow dose fentanyl prevents development of chronic neuropathic pain in rats.
Wala EP; Holtman JR; Sloan PA
J Opioid Manag; 2013; 9(2):85-96. PubMed ID: 23709318
[TBL] [Abstract][Full Text] [Related]
26. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
Nozaki C; Saitoh A; Kamei J
Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
[TBL] [Abstract][Full Text] [Related]
27. The antihyperalgesic effect of docosahexaenoic acid in streptozotocin-induced neuropathic pain in the rat involves the opioidergic system.
Landa-Juárez AY; Pérez-Severiano F; Castañeda-Hernández G; Ortiz MI; Chávez-Piña AE
Eur J Pharmacol; 2019 Feb; 845():32-39. PubMed ID: 30582909
[TBL] [Abstract][Full Text] [Related]
28. The spinal antinociceptive effects of cholinergic drugs in rats: receptor subtype specificity in different nociceptive tests.
Lograsso M; Nadeson R; Goodchild CS
BMC Pharmacol; 2002 Nov; 2():20. PubMed ID: 12441008
[TBL] [Abstract][Full Text] [Related]
29. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
30. The role of spinal opioid receptors in antinociceptive effects produced by intrathecal administration of hydromorphone and buprenorphine in the rat.
Tejwani GA; Rattan AK
Anesth Analg; 2002 Jun; 94(6):1542-6, table of contents. PubMed ID: 12032023
[TBL] [Abstract][Full Text] [Related]
31. Involvement of potassium channels in spinal antinociceptions induced by fentanyl, clonidine and bethanechol in rats.
Yamazumi I; Okuda T; Koga Y
Jpn J Pharmacol; 2001 Dec; 87(4):268-76. PubMed ID: 11829146
[TBL] [Abstract][Full Text] [Related]
32. Intrathecal co-administration of morphine and nimodipine produces higher antinociceptive effect by synergistic interaction as evident by injecting different doses of each drug in rats.
Gupta H; Verma D; Ahuja RK; Srivastava DN; Wadhwa S; Ray SB
Eur J Pharmacol; 2007 Apr; 561(1-3):46-53. PubMed ID: 17320072
[TBL] [Abstract][Full Text] [Related]
33. Supraspinal delta 2 opioid agonist analgesia in Swiss-Webster mice involves spinal GABAA receptors.
Rady JJ; Fujimoto JM
Pharmacol Biochem Behav; 1996 Jun; 54(2):363-9. PubMed ID: 8743596
[TBL] [Abstract][Full Text] [Related]
34. The spinal antinociceptive effect of nocistatin in neuropathic rats is blocked by D-serine.
Muth-Selbach U; Dybek E; Kollosche K; Stegmann JU; Holthusen H; Lipfert P; Zeilhofer HU
Anesthesiology; 2004 Sep; 101(3):753-8. PubMed ID: 15329601
[TBL] [Abstract][Full Text] [Related]
35. Antinociception by spinal and systemic oxycodone: why does the route make a difference? In vitro and in vivo studies in rats.
Lemberg KK; Kontinen VK; Siiskonen AO; Viljakka KM; Yli-Kauhaluoma JT; Korpi ER; Kalso EA
Anesthesiology; 2006 Oct; 105(4):801-12. PubMed ID: 17006080
[TBL] [Abstract][Full Text] [Related]
36. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
Miaskowski C; Levine JD
Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
[TBL] [Abstract][Full Text] [Related]
37. Antinociception after both peripheral and intrathecal injection of oxotremorine is modulated by spinal nitric oxide.
Machelska H; Pavone F; Capone F; Przewłocka B
Eur Neuropsychopharmacol; 1999 Mar; 9(3):213-7. PubMed ID: 10208290
[TBL] [Abstract][Full Text] [Related]
38. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues.
Gouardères C; Jhamandas K; Sutak M; Zajac JM
Br J Pharmacol; 1996 Feb; 117(3):493-501. PubMed ID: 8821539
[TBL] [Abstract][Full Text] [Related]
39. Antinociceptive role of 5-HT1A receptors in rat spinal cord.
Nadeson R; Goodchild CS
Br J Anaesth; 2002 May; 88(5):679-84. PubMed ID: 12067006
[TBL] [Abstract][Full Text] [Related]
40. Oxcarbazepine antinociception in animals with inflammatory pain or painful diabetic neuropathy.
Kiguchi S; Imamura T; Ichikawa K; Kojima M
Clin Exp Pharmacol Physiol; 2004; 31(1-2):57-64. PubMed ID: 14756685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
